His primary scientific interests are in Internal medicine, Endocrinology, Antidepressant, Single-nucleotide polymorphism and Psychiatry. The various areas that Manfred Uhr examines in his Internal medicine study include Oncology and Depression. As part of his studies on Endocrinology, Manfred Uhr often connects relevant subjects like Mechanism of action.
His Antidepressant research includes themes of Clinical trial, Pharmacology, Corticotropin-releasing hormone and Anxiety. His work deals with themes such as Genetic determinism and Candidate gene, which intersect with Single-nucleotide polymorphism. While the research belongs to areas of Psychiatry, Manfred Uhr spends his time largely on the problem of Pharmacogenetics, intersecting his research to questions surrounding Drug, Therapeutic drug monitoring and Tolerability.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Antidepressant, Depression and Psychiatry. His Internal medicine research integrates issues from Sleep in non-human animals and Single-nucleotide polymorphism. Ghrelin, Hormone, Adrenocorticotropic hormone, Glucocorticoid and Corticotropin-releasing hormone are among the areas of Endocrinology where he concentrates his study.
His studies in Ghrelin integrate themes in fields like Slow-wave sleep, Appetite and Leptin. He focuses mostly in the field of Antidepressant, narrowing it down to topics relating to Pharmacology and, in certain cases, Blood–brain barrier. Manfred Uhr mostly deals with Anxiety in his studies of Psychiatry.
His primary areas of investigation include Internal medicine, Endocrinology, Antidepressant, Depression and Psychiatry. His Internal medicine research is multidisciplinary, incorporating elements of Oncology, Cardiology, Genotype, Major depressive disorder and Trier social stress test. His Antidepressant study incorporates themes from Gene expression, Bioinformatics, Social defeat, Single-nucleotide polymorphism and Pharmacology.
His study looks at the relationship between Single-nucleotide polymorphism and fields such as Pharmacogenetics, as well as how they intersect with chemical problems. His Depression research is multidisciplinary, relying on both Quetiapine, Genotyping, Clinical psychology and Rating scale. His research investigates the connection between Psychiatry and topics such as Genome-wide association study that intersect with issues in Schizophrenia.
Manfred Uhr mainly investigates Internal medicine, Psychiatry, Endocrinology, Antidepressant and Major depressive disorder. His study explores the link between Internal medicine and topics such as Escitalopram that cross with problems in Corticotropin-releasing hormone and Antidepressant efficacy. His Psychiatry research is multidisciplinary, incorporating elements of Trier social stress test and Genome-wide association study.
His Endocrinology study frequently draws connections to other fields, such as Quetiapine. His Antidepressant research incorporates elements of Pharmacogenetics and Genotype. The Major depressive disorder study combines topics in areas such as Phenotype, Single-nucleotide polymorphism, Genetic association and Pharmacology, Drug.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone.
Nature Genetics (2013)
A mega-analysis of genome-wide association studies for major depressive disorder
Stephan Ripke;Naomi R Wray;Cathryn M Lewis;Steven P Hamilton.
Molecular Psychiatry (2013)
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment
Elisabeth B Binder;Daria Salyakina;Peter Lichtner;Gabriele M Wochnik.
Nature Genetics (2004)
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
C. Hiemke;P. Baumann;N. Bergemann;A. Conca.
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C. Hiemke;N. Bergemann;H. W. Clement;A. Conca.
Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
Astrid W. Zobel;Thomas Nickel;Annette Sonntag;Manfred Uhr.
Journal of Psychiatric Research (2001)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways
Colm O'Dushlaine;Lizzy Rossin;Phil H. Lee;Laramie Duncan;Laramie Duncan.
Nature Neuroscience (2015)
Polymorphisms in the drug transporter Gene ABCB1 predict antidepressant treatment response in depression
Manfred Uhr;Alina Tontsch;Christian Namendorf;Stephan Ripke.
Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
Marcus Ising;Sonja Horstmann;Stefan Kloiber;Susanne Lucae.
Biological Psychiatry (2007)
Ghrelin promotes slow-wave sleep in humans.
Jutta C. Weikel;Adam Wichniak;Marcus Ising;Hans Brunner.
American Journal of Physiology-endocrinology and Metabolism (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: